Latest News about PFE
Recent news which mentions PFE
3 Sweet Dividend Stocks to Treat Your Portfolio With This Halloween
October 25, 2024
From Motley Fool
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
October 24, 2024
From Benzinga
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
October 24, 2024
From Benzinga
5 High-Yield Dividend Stocks to Buy Without Hesitation
October 24, 2024
From Motley Fool
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
October 23, 2024
From Benzinga
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
October 23, 2024
From Benzinga
The Best Pharmaceutical Stock to Invest $1,000 in Right Now
October 23, 2024
Tickers
PFE
From Motley Fool
Activist Investor Starboard Slams Pfizer for Underperforming R&D And Overpaying for Acquisitions
October 22, 2024
From Benzinga
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
October 22, 2024
From Benzinga
Do Billionaires Israel Englander and Ken Griffin Know Something? Each Just Bought This Plagued Value Stock.
October 22, 2024
Tickers
PFE
From Motley Fool
From Motley Fool
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
October 19, 2024
From Motley Fool
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
October 18, 2024
From Motley Fool
From Benzinga
Guggenheim's Longstanding Pfizer Ties Tested Amid Starboard Battle
October 16, 2024
From Benzinga
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
October 15, 2024
From Benzinga
Tickers
PFE
From Motley Fool
2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 92% in 12 Months, According to Select Wall Street Analysts
October 15, 2024
From Motley Fool
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
October 14, 2024
From Motley Fool
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
October 14, 2024
From Benzinga
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
October 14, 2024
From Motley Fool
2 Unstoppable Growth Stocks to Buy Right Now for Less than $200
October 12, 2024
From Motley Fool
2 Incredibly Cheap Big Pharma Stocks to Buy Now
October 12, 2024
From Motley Fool
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now
October 12, 2024
From Motley Fool
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
October 11, 2024
From Benzinga
An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
October 11, 2024
Tickers
PFE
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.